Abiopharma

(30% Negative) OPTION CARE HEALTH, INC. (OPCH) Reports Q4 2025 Financial Results

(30% Negative) Cardinal Health, Inc. (CAH) Reports Q4 2025 Financial Results

Placements: Proposed Placement To Raise Gross Proceeds No Less Than S$5 Million - Receipt of LQN

Lilly reports third-quarter 2025 financial results, highlights R&D pipeline momentum and raises 2025 guidance

New Form 10-Q - Nuvalent, Inc. Filed: 2025-10-30 AccNo: 0001193125-25-257357 Size: 8 MB

(10% Negative) Merck & Co., Inc. (MRK) Reports Q4 2025 Financial Results

(10% Negative) NUVALENT, INC. (NUVL) Reports Q4 2025 Financial Results

(19% Negative) OMNICELL, INC. (OMCL) Reports Q4 2025 Financial Results

(10% Negative) Ekso Bionics Holdings, Inc. (EKSO) Announces Business Combination

New Form 10-Q - BIOGEN INC. Filed: 2025-10-30 AccNo: 0000875045-25-000049 Size: 17 MB

New Form 10-Q - COGNEX CORP Filed: 2025-10-30 AccNo: 0000851205-25-000064 Size: 8 MB

(30% Negative) Agios Pharmaceuticals, Inc. (AGIO) Reports Q4 2025 Financial Results

Westlake Corporation Reports Third Quarter 2025 Results

Agios Reports Third Quarter 2025 Financial Results and Provides Business Update

(30% Negative) AMNEAL PHARMACEUTICALS, INC. (AMRX) Reports Q4 2025 Financial Results